Showing results (1-10 of 543) with videos related to
Sort By:
Pageof 55
Blood|January 15, 2009
Activin-A attenuates several human natural killer cell functionsNeil C Robson, Heng Wei, Tristan McAlpine, et al.Blood|May 1, 2010
Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen deliveryNeil C Robson, Tristan McAlpine, Ashley J Knights, et al.Blood|December 25, 2007
Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine productionNeil C Robson, David J Phillips, Tristan McAlpine, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase IIMax Schnurr, Martin Orban, Neil C Robson, et al.Current Opinion in Immunology|February 2, 2010
Presentation of tumour antigens by dendritic cells and challenges facedNeil C Robson, Sabine Hoves, Eugene Maraskovsky, et al.Blood|October 16, 2004
Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathwayMax Schnurr, Tracey Toy, Amanda Shin, et al.Cancer Research|July 20, 2014
Optimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signalingNeil C Robson, Laura Hidalgo, Tristan Mc Alpine, et al.Immunology and Cell Biology|April 22, 2009
Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvantEugene Maraskovsky, Max Schnurr, Nick S Wilson, et al.Immunology and Cell Biology|May 10, 2006
Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1Theo Nicholaou, Lisa Ebert, Ian D Davis, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2002
IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activationThomas Luft, Michael Jefford, Petra Luetjens, et al.Pageof 55